Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 103029
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.103029
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.103029
Table 3 Best response, n (%)
| PA < 4.60° (n = 63) | PA ≥ 4.60° (n = 81) | P (χ2) value | ||
| CR | 4 (2.8) | 2 (3.2) | 2 (2.5) | |
| PR | 69 (47.9) | 25 (39.7) | 44 (54.3) | |
| SD | 52 (36.1) | 20 (31.7) | 32 (39.5) | |
| PD | 19 (13.2) | 16 (25.4) | 3 (3.7) | |
| CR + PR | 73 (50.7) | 27 (42.9) | 46 (56.8) | 0.097 |
| DCR (CR + PR + SD) | 125 (86.8) | 47 (74.6) | 78 (96.3) | < 0.001 |
- Citation: Kekez D, Prejac J, Adžić G, Librenjak N, Goršić I, Jonjić D, Krznarić Ž, Augustin G, Pleština S. Phase angle as a prognostic biomarker in metastatic colorectal cancer: A prospective trial. World J Gastrointest Oncol 2025; 17(4): 103029
- URL: https://www.wjgnet.com/1948-5204/full/v17/i4/103029.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.103029